Home » Newsletters » BioWorld

BioWorld

May 18, 2009

View Archived Issues

GlobeImmune, Celgene Form $540M Cancer Partnership

Celgene Corp. will pay GlobeImmune Inc. $40 million up-front to gain access to all of the company's cancer drug programs. (BioWorld Today) Read More

Economy Cuts Attendance but Not Fervor as BIO Heads South

What to Do and What to See at BIO 2009 in Atlanta

DeveloGen's Preclinical Diabetes Package Draws $330M from BI

NYC Health Commissioner Tapped for Top CDC Post

Clinic Roundup

Other News To Note

Financings Roundup